Document is current
Any future updates will be listed below
-
Authors
Gustafsson, Stefan
Lampa, Erik
Jensevik Eriksson, Karin https://orcid.org/0000-0003-1946-7068
Butterworth, Adam S. https://orcid.org/0000-0002-6915-9015
Elmståhl, Sölve
Engström, Gunnar
Hveem, Kristian
Johansson, Mattias
Langhammer, Arnulf
Lind, Lars
Läll, Kristi
Masala, Giovanna
Metspalu, Andres
Moreno-Iribas, Conchi
Nilsson, Peter M.
Perola, Markus
Simell, Birgit
Sipsma, Hemmo
Åsvold, Bjørn Olav
Ingelsson, Erik
Hammar, Ulf
Ganna, Andrea
Svennblad, Bodil
Fall, Tove
Sundström, Johan https://orcid.org/0000-0003-2247-8454
-
Funding
Funding for this research was provided by:
AFA Försäkring (160266)
Vetenskapsrådet (2016-01065)
Hjärt-Lungfonden (20160734)
- License Information
-
More Information
Article History
Received: 28 April 2023
Accepted: 4 January 2024
First Online: 12 February 2024
Competing interests
: The authors declare the following competing interests: A.S.B. reports grants outside this work (from AstraZeneca, Bayer, Biogen, BioMarin, Bioverativ, Novartis and Sanofi) and personal fees from Novartis. E.I. is now an employee at GlaxoSmithKline. S.G. is an employee of Sence Research AB. J.S. reports stock ownership in Anagram kommunikation AB and Symptoms Europe AB outside the submitted work. All other authors declare no competing interests.
